---
figid: PMC8529056__fnmol-14-751307-g001
figtitle: 'Testing Fmr1KO Phenotypes in Response to GSK3 Inhibitors: SB216763 versus
  AFC03127'
organisms:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- Matthiola incana
organisms_ner:
- Drosophila melanogaster
- Mus musculus
- Homo sapiens
pmcid: PMC8529056
filename: fnmol-14-751307-g001.jpg
figlink: /pmc/articles/PMC8529056/figure/F1/
number: F1
caption: GSK3 activation affects all major hallmarks of Alzheimer’s disease and FXS.
  GSK3 signals downstream of mGluR5 and upstream of FMRP. The mGluR5/FMRP signaling
  pathway modulates the cellular protein synthesis of numerous FMRP target mRNAs including
  App mRNA. Genetic reduction of App by 50% in Fmr1KO mice rescues behavioral, dendritic
  spine and electrophysiological phenotypes. GSK3 modulates APP and Aβ levels through
  phosphorylation of the carboxy-terminus of APP and via regulation of secretase enzymes
  involved in amyloidogenic processing of APP. The Aβ metabolite of APP can induce
  GSK3 activity suggesting a positive feedback regulatory loop.
papertitle: 'Testing Fmr1KO Phenotypes in Response to GSK3 Inhibitors: SB216763 versus
  AFC03127.'
reftext: Pamela R. Westmark, et al. Front Mol Neurosci. 2021;14:751307.
year: '2021'
doi: 10.3389/fnmol.2021.751307
journal_title: Frontiers in Molecular Neuroscience
journal_nlm_ta: Front Mol Neurosci
publisher_name: Frontiers Media S.A.
keywords: fragile X syndrome | glycogen synthase kinase | amyloid precursor protein
  | metabotropic glutamate receptor 5 | seizure
automl_pathway: 0.8549032
figid_alias: PMC8529056__F1
figtype: Figure
redirect_from: /figures/PMC8529056__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8529056__fnmol-14-751307-g001.html
  '@type': Dataset
  description: GSK3 activation affects all major hallmarks of Alzheimer’s disease
    and FXS. GSK3 signals downstream of mGluR5 and upstream of FMRP. The mGluR5/FMRP
    signaling pathway modulates the cellular protein synthesis of numerous FMRP target
    mRNAs including App mRNA. Genetic reduction of App by 50% in Fmr1KO mice rescues
    behavioral, dendritic spine and electrophysiological phenotypes. GSK3 modulates
    APP and Aβ levels through phosphorylation of the carboxy-terminus of APP and via
    regulation of secretase enzymes involved in amyloidogenic processing of APP. The
    Aβ metabolite of APP can induce GSK3 activity suggesting a positive feedback regulatory
    loop.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - spn-E
  - Fmr1
  - sgg
  - ab
  - Appl
  - tau
  - Apoltp
  - app
  - ApepP
  - APP-BP1
  - Gsk3b
  - Grm5
  - App
  - H2-Ab1
  - Mapt
  - Csnk1e
  - Ltp
  - FMR1
  - GSK3A
  - GSK3B
  - GRM5
  - APP
  - SUCLA2
  - MAPT
---
